Revelation Biosciences, Inc.

REVBNASDAQ Capital Market·USD·Closed

REVBNASDAQ·USD·Closed

$0.95

−4.56%

$0.95

−$0.05 (4.56%)

52W Range

1thpctl

Volume

0.39×avg

Mkt Cap

3.71MUSD

P/E

-0.1TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.39×avg

Market Cap

3.71MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-73.2%

Financially safe

Stretched

Debt / equity0.06×

Interest coverage0.0×

Current ratio10.02×